GoHearing Ultra vs Signia Pure Charge&Go MaX

The GoHearing Ultra is a budget-priced behind-the-ear OTC hearing aid that earns a B grade with a SoundScore of 3.1/5 in our lab testing. At $499, it sits in the most affordable price tier of the OTC market, though its overall sound performance ranks #58 of 65 devices in its category. In our testing, the Ultra shows a distinctive performance profile with significant strengths and weaknesses. Feedback handling is excellent at 5.0/5, scoring 0.46 points above the category average—users can expect stable operation without whistling during typical wear. Music streaming quality is also a genuine strength at 3.6/5, performing 1.68 points above average, making it notably better for phone audio than most OTC devices. However, speech clarity scores reveal meaningful limitations. Speech in quiet environments measured just 1.0/5, which is 1.79 points below the category average and low in absolute terms. Speech in noise similarly scored 1.0/5, falling 0.48 points below average. Own-voice comfort rated 1.9/5, also below the category norm. These results suggest the Ultra may struggle to deliver the speech audibility improvements that many users prioritize. The GoHearing Ultra may suit budget-conscious consumers who primarily want reliable streaming audio and feedback-free operation, and who have modest expectations for speech enhancement. However, several competitors in the same price range—including the Elehear Beyond and Apple AirPods Pro 2—deliver substantially stronger overall sound performance. Users prioritizing speech clarity should consider these alternatives despite similar pricing.

The Signia Pure Charge&Go MaX is a behind-the-ear prescription hearing aid released in 2026 that earns an A grade with a SoundScore of 4.3/5 in HearAdvisor's lab testing. This strong overall performance reflects solid results across key listening scenarios, with particular strengths in own-voice comfort and speech understanding in noisy environments. In our testing, the Pure Charge&Go MaX demonstrated notable advantages over the prescription hearing aid category average. Own-voice comfort scored 1.00 points above the category average at 3.7/5, suggesting effective management of occlusion-related issues that many hearing aid users find bothersome. Speech in noise performance measured 0.65 points above average at 2.8/5—above the category average, but only mixed in absolute terms, indicating room for improvement in the most challenging listening situations. Speech in quiet scored a solid 3.6/5, landing 0.24 points above the category average. Music streaming measured 2.9/5, slightly above average but mixed in absolute terms. Feedback handling scored an excellent 4.6/5 in absolute terms, though this fell 0.12 points below the category average of 4.72/5, reflecting the generally strong feedback control across modern prescription devices. The device showed meaningful improvement from initial to tuned fitting, with the normalized score rising from 4.2/5 to 4.6/5 after professional adjustment. This suggests that working with a hearing care professional to optimize settings can unlock additional performance, particularly for speech understanding. The Pure Charge&Go MaX appears well-suited for users who prioritize natural own-voice quality and improved conversation clarity in moderately noisy settings.